Cellectis (CLLS) PT Raised to $6 at Jefferies
Tweet Send to a Friend
Jefferies analyst Clara Dong raised the price target on Cellectis (NASDAQ: CLLS) to $6.00 (from $5.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


